ICH Guideline Q5A(R2) Public Consultation (Cell and Gene Therapy Catapult – Regulatory Round-up – October 2022)
A public consultation is held until 10th of February 2023 for the ICH Guideline Q5A(R2) on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin.
See all of Catapult’s Regulatory Round-up for October 2022 here. Published on the 7th of November 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (25 janvier 2023). ICH Guideline Q5A(R2) Public Consultation (Cell and Gene Therapy Catapult – Regulatory Round-up – October 2022). ELSIBI. Consulté le 5 mars 2026 à l’adresse https://doi.org/10.58079/o678





